Replies to post #73288 on Biotech Values

[zipjet]

It sort of depends on the date on which you are valuing the CVR's.

I would have placed little or no value on CVR2 until the recent accelerated review and the PDUFA of 6/3. But with that in hand and no indication that CSL has filed a complete response, the chance that LEVP lapped them increased.